Results
|
421.
|
|
|
422.
|
|
|
423.
|
|
|
424.
|
|
|
425.
|
|
|
426.
|
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. [electronic resource] by
- Walter, B
- Schrettenbrunner, I
- Vogelhuber, M
- Grassinger, J
- Bross, K
- Wilke, J
- Suedhoff, T
- Berand, A
- Wieland, W F
- Rogenhofer, S
- Andreesen, R
- Reichle, A
Producer: 20120918
In:
Medical oncology (Northwood, London, England) vol. 29
Availability: No items available.
|
|
427.
|
|
|
428.
|
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. [electronic resource] by
- Bingham, C O
- Sebba, A I
- Rubin, B R
- Ruoff, G E
- Kremer, J
- Bird, S
- Smugar, S S
- Fitzgerald, B J
- O'Brien, K
- Tershakovec, A M
Producer: 20070509
In:
Rheumatology (Oxford, England) vol. 46
Availability: No items available.
|
|
429.
|
|
|
430.
|
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. [electronic resource] by
- Gottesdiener, K
- Schnitzer, T
- Fisher, C
- Bockow, B
- Markenson, J
- Ko, A
- DeTora, L
- Curtis, S
- Geissler, L
- Gertz, B J
Producer: 20021028
In:
Rheumatology (Oxford, England) vol. 41
Availability: No items available.
|
|
431.
|
|
|
432.
|
|
|
433.
|
|
|
434.
|
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. [electronic resource] by
- Riendeau, D
- Percival, M D
- Brideau, C
- Charleson, S
- Dubé, D
- Ethier, D
- Falgueyret, J P
- Friesen, R W
- Gordon, R
- Greig, G
- Guay, J
- Mancini, J
- Ouellet, M
- Wong, E
- Xu, L
- Boyce, S
- Visco, D
- Girard, Y
- Prasit, P
- Zamboni, R
- Rodger, I W
- Gresser, M
- Ford-Hutchinson, A W
- Young, R N
- Chan, C C
Producer: 20010405
In:
The Journal of pharmacology and experimental therapeutics vol. 296
Availability: No items available.
|
|
435.
|
|
|
436.
|
|
|
437.
|
|
|
438.
|
|
|
439.
|
|
|
440.
|
|